Cargando…
Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages( )
To investigate if the AY.4.2 sublineage of the SARS-CoV-2 delta variant is associated with hospitalization and mortality risks that differ from non-AY.4.2 delta risks, we performed a retrospective cohort study of sequencing-confirmed COVID-19 cases in England based on linkage of routine health care...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903446/ https://www.ncbi.nlm.nih.gov/pubmed/35184201 http://dx.doi.org/10.1093/infdis/jiac063 |
_version_ | 1784664744555184128 |
---|---|
author | Nyberg, Tommy Harman, Katie Zaidi, Asad Seaman, Shaun R Andrews, Nick Nash, Sophie G Charlett, Andre Lopez Bernal, Jamie Myers, Richard Groves, Natalie Gallagher, Eileen Gharbia, Saheer Chand, Meera Thelwall, Simon De Angelis, Daniela Dabrera, Gavin Presanis, Anne M |
author_facet | Nyberg, Tommy Harman, Katie Zaidi, Asad Seaman, Shaun R Andrews, Nick Nash, Sophie G Charlett, Andre Lopez Bernal, Jamie Myers, Richard Groves, Natalie Gallagher, Eileen Gharbia, Saheer Chand, Meera Thelwall, Simon De Angelis, Daniela Dabrera, Gavin Presanis, Anne M |
author_sort | Nyberg, Tommy |
collection | PubMed |
description | To investigate if the AY.4.2 sublineage of the SARS-CoV-2 delta variant is associated with hospitalization and mortality risks that differ from non-AY.4.2 delta risks, we performed a retrospective cohort study of sequencing-confirmed COVID-19 cases in England based on linkage of routine health care datasets. Using stratified Cox regression, we estimated adjusted hazard ratios (aHR) of hospital admission (aHR = 0.85; 95% confidence interval [CI], .77–.94), hospital admission or emergency care attendance (aHR = 0.87; 95% CI, .81–.94), and COVID-19 mortality (aHR = 0.85; 95% CI, .71–1.03). The results indicate that the risks of hospitalization and mortality are similar or lower for AY.4.2 compared to cases with other delta sublineages. |
format | Online Article Text |
id | pubmed-8903446 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-89034462022-03-09 Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages( ) Nyberg, Tommy Harman, Katie Zaidi, Asad Seaman, Shaun R Andrews, Nick Nash, Sophie G Charlett, Andre Lopez Bernal, Jamie Myers, Richard Groves, Natalie Gallagher, Eileen Gharbia, Saheer Chand, Meera Thelwall, Simon De Angelis, Daniela Dabrera, Gavin Presanis, Anne M J Infect Dis Brief Report To investigate if the AY.4.2 sublineage of the SARS-CoV-2 delta variant is associated with hospitalization and mortality risks that differ from non-AY.4.2 delta risks, we performed a retrospective cohort study of sequencing-confirmed COVID-19 cases in England based on linkage of routine health care datasets. Using stratified Cox regression, we estimated adjusted hazard ratios (aHR) of hospital admission (aHR = 0.85; 95% confidence interval [CI], .77–.94), hospital admission or emergency care attendance (aHR = 0.87; 95% CI, .81–.94), and COVID-19 mortality (aHR = 0.85; 95% CI, .71–1.03). The results indicate that the risks of hospitalization and mortality are similar or lower for AY.4.2 compared to cases with other delta sublineages. Oxford University Press 2022-02-20 /pmc/articles/PMC8903446/ /pubmed/35184201 http://dx.doi.org/10.1093/infdis/jiac063 Text en © The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Report Nyberg, Tommy Harman, Katie Zaidi, Asad Seaman, Shaun R Andrews, Nick Nash, Sophie G Charlett, Andre Lopez Bernal, Jamie Myers, Richard Groves, Natalie Gallagher, Eileen Gharbia, Saheer Chand, Meera Thelwall, Simon De Angelis, Daniela Dabrera, Gavin Presanis, Anne M Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages( ) |
title | Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages( ) |
title_full | Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages( ) |
title_fullStr | Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages( ) |
title_full_unstemmed | Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages( ) |
title_short | Hospitalization and Mortality Risk for COVID-19 Cases With SARS-CoV-2 AY.4.2 (VUI-21OCT-01) Compared to Non-AY.4.2 Delta Variant Sublineages( ) |
title_sort | hospitalization and mortality risk for covid-19 cases with sars-cov-2 ay.4.2 (vui-21oct-01) compared to non-ay.4.2 delta variant sublineages( ) |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8903446/ https://www.ncbi.nlm.nih.gov/pubmed/35184201 http://dx.doi.org/10.1093/infdis/jiac063 |
work_keys_str_mv | AT nybergtommy hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages AT harmankatie hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages AT zaidiasad hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages AT seamanshaunr hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages AT andrewsnick hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages AT nashsophieg hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages AT charlettandre hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages AT lopezbernaljamie hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages AT myersrichard hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages AT grovesnatalie hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages AT gallaghereileen hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages AT gharbiasaheer hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages AT chandmeera hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages AT thelwallsimon hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages AT deangelisdaniela hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages AT dabreragavin hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages AT presanisannem hospitalizationandmortalityriskforcovid19caseswithsarscov2ay42vui21oct01comparedtononay42deltavariantsublineages |